Real-world treatment sequencing and outcomes for patients with advanced renal cell carcinoma treated with cabozantinib after first-line checkpoint inhibitor-based combination therapy: Results from the CARINA study
Nathan, P. D. Allison, Jennifer Charnley, N. Griffiths, R. Michael, A. Moore, K. Sharma, A. Szabados, B. Venugopal, B. Ali, J.
Nathan, P. D.
Allison, Jennifer
Charnley, N.
Griffiths, R.
Michael, A.
Moore, K.
Sharma, A.
Szabados, B.
Venugopal, B.
Ali, J.
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Nathan PD, Allison J, Charnley N, Griffiths R, Michael A, Moore K, et al. Real-world treatment sequencing and outcomes for patients with advanced renal cell carcinoma treated with cabozantinib after first-line checkpoint inhibitor-based combination therapy: Results from the CARINA study. Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772002367.